<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31460675</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1749-6632</ISSN><JournalIssue CitedMedium="Internet"><Volume>1457</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of the New York Academy of Sciences</Title><ISOAbbreviation>Ann N Y Acad Sci</ISOAbbreviation></Journal><ArticleTitle>Endoplasmic reticulum-mitochondria crosstalk: from junction to function across neurological disorders.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>60</EndPage><MedlinePgn>41-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nyas.14212</ELocationID><Abstract><AbstractText>The endoplasmic reticulum (ER) and mitochondria are fundamental organelles highly interconnected with a specialized set of proteins in cells. ER-mitochondrial interconnections form specific microdomains, called mitochondria-associated ER membranes, that have been found to play important roles in calcium signaling and lipid homeostasis, and more recently in mitochondrial dynamics, inflammation, and autophagy. It is not surprising that perturbations in ER-mitochondria connections can result in the progression of disease, especially neurological disorders; hence, their architecture and regulation are crucial in determining the fate of cells and disease. The molecular identity of the specialized proteins regulating ER-mitochondrial crosstalk remains unclear. Our discussion here describes the physical and functional crosstalk between these two dynamic organelles and emphasizes the outcome of altered ER-mitochondrial interconnections in neurological disorders.</AbstractText><CopyrightInformation>&#xa9; 2019 New York Academy of Sciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Veeresh</LastName><ForeName>Pabbala</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Harpreet</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarmah</LastName><ForeName>Deepaneeta</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut Mondor de Recherche Biom&#xe9;dicale (IMRB), INSERM U955, Universit&#xe9; Paris-Est, UMR-S955, UPEC, Cret&#xe9;il, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mounica</LastName><ForeName>Leela</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Geetesh</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotian</LastName><ForeName>Vignesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kesharwani</LastName><ForeName>Radhika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalia</LastName><ForeName>Kiran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borah</LastName><ForeName>Anupom</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Neurobiology Laboratory, Department of Life Science and Bioinformatics, Assam University, Silchar, Assam, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dave</LastName><ForeName>Kunjan R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Anne-Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Institut Mondor de Recherche Biom&#xe9;dicale (IMRB), INSERM U955, Universit&#xe9; Paris-Est, UMR-S955, UPEC, Cret&#xe9;il, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yavagal</LastName><ForeName>Dileep R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, University of Miami Miller School of Medicine, Miami, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharya</LastName><ForeName>Pallab</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2867-1650</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SB/YS/LS-196/2014</GrantID><Agency>Department of Science and Technology (DST), Government of India</Agency><Country>International</Country></Grant><Grant><Agency>Department of Pharmaceuticals, Ministry of Chemical and Fertilizers, Government of India</Agency><Country>International</Country></Grant><Grant><Agency>National Institute of Pharmaceutical Education and Research</Agency><Country>International</Country></Grant><Grant><Agency>International Society for Neurochemistry</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann N Y Acad Sci</MedlineTA><NlmUniqueID>7506858</NlmUniqueID><ISSNLinking>0077-8923</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033681">Mitochondrial Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499638">PACS2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053763">Presenilins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D020558">GTP Phosphohydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.-</RegistryNumber><NameOfSubstance UI="C470017">Mfn1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059865" MajorTopicYN="N">Endoplasmic Reticulum Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020558" MajorTopicYN="N">GTP Phosphohydrolases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063154" MajorTopicYN="N">Mitochondrial Dynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033681" MajorTopicYN="N">Mitochondrial Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051336" MajorTopicYN="N">Mitochondrial Membranes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053763" MajorTopicYN="N">Presenilins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">ERMES</Keyword><Keyword MajorTopicYN="N">Huntington's disease</Keyword><Keyword MajorTopicYN="N">MAMs</Keyword><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cerebral ischemia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31460675</ArticleId><ArticleId IdType="doi">10.1111/nyas.14212</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Rimessi, A. et&#xa0;al. 2015. Mitochondrial Ca2+ remodeling is a prime factor in oncogenic behavior. Front. Oncol. 5: 143.</Citation></Reference><Reference><Citation>Bittremieux, M. et&#xa0;al. 2016. ER functions of oncogenes and tumor suppressors: modulators of intracellular Ca2+ signaling. Biochim. Biophys. Acta 1863: 1364-1378.</Citation></Reference><Reference><Citation>Stankov, K., B. Stanimirov &amp; M. Mikov. 2014. Cellular responses to endoplasmic reticulum stress. Biol. Serb. 35: 15-23.</Citation></Reference><Reference><Citation>Hollien, J. 2013. Evolution of the unfolded protein response. Biochim. Biophys. Acta 1833: 2458-2463.</Citation></Reference><Reference><Citation>Lai, E., T. Teodoro &amp; A. Volchuk. 2007. Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology 22: 193-201.</Citation></Reference><Reference><Citation>Ron, D. &amp; P. Walter. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8: 519-529.</Citation></Reference><Reference><Citation>Walter, P. &amp; D. Ron. 2011. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334: 1081-1086.</Citation></Reference><Reference><Citation>Kraskiewicz, H. &amp; U. FitzGerald. 2012. InterfERing with endoplasmic reticulum stress. Trends Pharmacol. Sci. 33: 53-63.</Citation></Reference><Reference><Citation>Hetz, C. 2012. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13: 89-102.</Citation></Reference><Reference><Citation>Mukherjee, R. &amp; O. Chakrabarti. 2013. Mitochondrial quality control: decommissioning power plants in neurodegenerative diseases. Sci. World J. 2013. http://doi.org/10.1155/2013/180759.</Citation></Reference><Reference><Citation>Mattson, M.P., M. Gleichmann &amp; A. Cheng. 2008. Mitochondria in neuroplasticity and neurological disorders. Neuron 60: 748-766.</Citation></Reference><Reference><Citation>Vafai, S.B. &amp; V.K. Mootha. 2012. Mitochondrial disorders as windows into an ancient organelle. Nature 491: 374-383.</Citation></Reference><Reference><Citation>Lin, M.T. &amp; M.F. Beal. 2006. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795.</Citation></Reference><Reference><Citation>Nita, M. &amp; A. Grzybowski. 2016. The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxid. Med. Cell. Longev. 2016. http://doi.org/10.1155/2016/3164734.</Citation></Reference><Reference><Citation>Hollenbeck, P.J. &amp; W.M. Saxton. 2005. The axonal transport of mitochondria. J. Cell Sci. 118: 5411-5419.</Citation></Reference><Reference><Citation>Murley, A. &amp; J. Nunnari. 2016. The emerging network of mitochondria-organelle contacts. Mol. Cell 61: 648-653.</Citation></Reference><Reference><Citation>Bernhard, W. &amp; C. Rouiller. 1956. Close topographical relationship between mitochondria and ergastoplasm of liver cells in a definite phase of cellular activity. J. Cell Biol. 2: 73-78.</Citation></Reference><Reference><Citation>Rowland, A.A. &amp; G.K. Voeltz. 2012. Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat. Rev. Mol. Cell Biol. 13: 607-625.</Citation></Reference><Reference><Citation>Mueller, S.J. &amp; R. Reski. 2015. Mitochondrial dynamics and the ER: the plant perspective. Front. Cell Dev. Biol. 3: 78.</Citation></Reference><Reference><Citation>Erpapazoglou, Z., F. Mouton-Liger &amp; O. Corti. 2017. From dysfunctional endoplasmic reticulum-mitochondria coupling to neurodegeneration. Neurochem. Int. 109: 171-183.</Citation></Reference><Reference><Citation>Arruda, A.P. et&#xa0;al. 2014. Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat. Med. 20: 1427-1435.</Citation></Reference><Reference><Citation>Doghman-Bouguerra, M. &amp; E. Lalli. 2019. ER-mitochondria interactions: both strength and weakness within cancer cells. Biochim. Biophys. Acta Mol. Cell Res. 1866: 650-662.</Citation></Reference><Reference><Citation>Giacomello, M. &amp; L. Pellegrini. 2016. The coming of age of the mitochondria-ER contact: a matter of thickness. Cell Death Differ. 23: 1417-1427.</Citation></Reference><Reference><Citation>Csord&#xe1;s, G. et&#xa0;al. 2006. Structural and functional features and significance of the physical linkage between ER and mitochondria. J. Cell Biol. 174: 915-921.</Citation></Reference><Reference><Citation>Area-Gomez, E. et&#xa0;al. 2012. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 31: 4106-4123.</Citation></Reference><Reference><Citation>Fujimoto, M., T. Hayashi &amp; T.-P. Su. 2012. The role of cholesterol in the association of endoplasmic reticulum membranes with mitochondria. Biochem. Biophys. Res. Commun. 417: 635-639.</Citation></Reference><Reference><Citation>Poston, C.N., S.C. Krishnan &amp; C.R. Bazemore-Walker. 2013. In-depth proteomic analysis of mammalian mitochondria-associated membranes (MAM). J. Proteomics 79: 219-230.</Citation></Reference><Reference><Citation>Kornmann, B. et&#xa0;al. 2009. An ER-mitochondria tethering complex revealed by a synthetic biology screen. Science 325: 477-481.</Citation></Reference><Reference><Citation>Lee, I. &amp; W. Hong. 2006. Diverse membrane-associated proteins contain a novel SMP domain. FASEB J. 20: 202-206.</Citation></Reference><Reference><Citation>Schauder, C.M. et&#xa0;al. 2014. Structure of a lipid-bound extended synaptotagmin indicates a role in lipid transfer. Nature 510: 552-555.</Citation></Reference><Reference><Citation>Toulmay, A. &amp; W.A. Prinz. 2012. A conserved membrane-binding domain targets proteins to organelle contact sites. J. Cell Sci. 125: 49-58.</Citation></Reference><Reference><Citation>Kornmann, B., C. Osman &amp; P. Walter. 2011. The conserved GTPase Gem1 regulates endoplasmic reticulum-mitochondria connections. Proc. Natl. Acad. Sci. USA 108: 14151-14156.</Citation></Reference><Reference><Citation>AhYoung, A.P. et&#xa0;al. 2015. Conserved SMP domains of the ERMES complex bind phospholipids and mediate tether assembly. Proc. Natl. Acad. Sci. USA 112: E3179-E3188.</Citation></Reference><Reference><Citation>Lang, A., A.T.J. Peter &amp; B. Kornmann. 2015. ER-mitochondria contact sites in yeast: beyond the myths of ERMES. Curr. Opin. Cell Biol. 35: 7-12.</Citation></Reference><Reference><Citation>Lahiri, S. et&#xa0;al. 2014. A conserved endoplasmic reticulum membrane protein complex (EMC) facilitates phospholipid transfer from the ER to mitochondria. PLoS Biol. 12: e1001969.</Citation></Reference><Reference><Citation>Satoh, T. et&#xa0;al. 2015. dPob/EMC is essential for biosynthesis of rhodopsin and other multi-pass membrane proteins in Drosophila photoreceptors. elife 4: e06306.</Citation></Reference><Reference><Citation>Murley, A. et&#xa0;al. 2015. Ltc1 is an ER-localized sterol transporter and a component of ER-mitochondria and ER-vacuole contacts. J. Cell Biol. 209: 539-548.</Citation></Reference><Reference><Citation>Rice, S.E. &amp; V.I. Gelfand. 2006. Paradigm lost: milton connects kinesin heavy chain to miro on mitochondria. J. Cell Biol. 173: 459-461.</Citation></Reference><Reference><Citation>Simmen, T. et&#xa0;al. 2005. PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J. 24: 717-729.</Citation></Reference><Reference><Citation>Youker, R.T. et&#xa0;al. 2009. At the crossroads of homoeostasis and disease: roles of the PACS proteins in membrane traffic and apoptosis. Biochem. J. 421: 1-15.</Citation></Reference><Reference><Citation>Filadi, R. et&#xa0;al. 2016. Presenilin 2 modulates endoplasmic reticulum-mitochondria coupling by tuning the antagonistic effect of mitofusin 2. Cell Rep. 15: 2226-2238.</Citation></Reference><Reference><Citation>Goedert, M. &amp; M.G. Spillantini. 2006. A century of Alzheimer's disease. Science 314: 777-781.</Citation></Reference><Reference><Citation>Mattson, M.P. 2010. ER calcium and Alzheimer's disease: in a state of flux. Sci. Signal. 3: pe10.</Citation></Reference><Reference><Citation>Zampese, E. et&#xa0;al. 2011. Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ crosstalk. Proc. Natl. Acad. Sci. USA 108: 2777-2782.</Citation></Reference><Reference><Citation>Zampese, E. et&#xa0;al. 2009. Ca 2+ dysregulation mediated by presenilins in familial Alzheimer's disease: causing or modulating factor. Curr. Trends Neurol. 3: 1-14.</Citation></Reference><Reference><Citation>Tu, H. et&#xa0;al. 2006. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126: 981-993.</Citation></Reference><Reference><Citation>Nelson, O. et&#xa0;al. 2007. Familial Alzheimer disease-linked mutations specifically disrupt Ca 2+ leak function of presenilin 1. J. Clin. Invest. 117: 1230-1239.</Citation></Reference><Reference><Citation>Green, K.N. et&#xa0;al. 2008. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid &#x3b2; production. J. Cell Biol. 181: 1107-1116.</Citation></Reference><Reference><Citation>Brunello, L. et&#xa0;al. 2009. Presenilin-2 dampens intracellular Ca2+ stores by increasing Ca2+ leakage and reducing Ca2+ uptake. J. Cell. Mol. Med. 13: 3358-3369.</Citation></Reference><Reference><Citation>Celsi, F. et&#xa0;al. 2009. Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim. Biophys. Acta 1787: 335-344.</Citation></Reference><Reference><Citation>Swerdlow, R.H., J.M. Burns &amp; S.M. Khan. 2010. The Alzheimer's disease mitochondrial cascade hypothesis. J. Alzheimers Dis. 20: S265-S279.</Citation></Reference><Reference><Citation>Szabadkai, G. et&#xa0;al. 2006. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J. Cell Biol. 175: 901-911.</Citation></Reference><Reference><Citation>Baughman, J.M. et&#xa0;al. 2011. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476: 341-345.</Citation></Reference><Reference><Citation>Morciano, G. et&#xa0;al. 2018. Role of mitochondria-associated ER membranes in calcium regulation in cancer-specific settings. Neoplasia 20: 510-523.</Citation></Reference><Reference><Citation>Mendes, C.C. et&#xa0;al. 2005. The type III inositol 1, 4, 5-trisphosphate receptor preferentially transmits apoptotic Ca2+ signals into mitochondria. J. Biol. Chem. 280: 40892-40900.</Citation></Reference><Reference><Citation>Rapizzi, E. et&#xa0;al. 2002. Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. J. Cell Biol. 159: 613-624.</Citation></Reference><Reference><Citation>Hayashi, T. &amp; T.-P. Su. 2007. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca 2+ signaling and cell survival. Cell 131: 596-610.</Citation></Reference><Reference><Citation>Ouyang, Y.-B. &amp; R.G. Giffard. 2012. ER-mitochondria crosstalk during cerebral ischemia: molecular chaperones and ER-mitochondrial calcium transfer. Int. J. Cell Biol. 2012. http://doi.org/10.1155/2012/493934.</Citation></Reference><Reference><Citation>Marchi, S., S. Patergnani &amp; P. Pinton. 2014. The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim. Biophys. Acta 1837: 461-469.</Citation></Reference><Reference><Citation>Chen, H. et&#xa0;al. 2003. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160: 189-200.</Citation></Reference><Reference><Citation>de Brito, O.M. &amp; L. Scorrano. 2008. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456: 605.</Citation></Reference><Reference><Citation>Ishihara, N., Y. Eura &amp; K. Mihara. 2004. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J. Cell Sci. 117: 6535-6546.</Citation></Reference><Reference><Citation>De Vos, K.J. et&#xa0;al. 2011. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet. 21: 1299-1311.</Citation></Reference><Reference><Citation>Stoica, R. et&#xa0;al. 2014. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun. 5: 3996.</Citation></Reference><Reference><Citation>Chung, J. et&#xa0;al. 2015. PI4P/phosphatidylserine countertransport at ORP5- and ORP8-mediated ER-plasma membrane contacts. Science 349: 428-432.</Citation></Reference><Reference><Citation>Lombardi, A.A. &amp; J.W. Elrod. 2017. Mediating ER-mitochondrial crosstalk. Science 358: 591-592.</Citation></Reference><Reference><Citation>Rajagopal, S. &amp; M. Ponnusamy. 2017. Calcium signalling in neurological disorders. In Calcium Signaling: From Physiology to Diseases. 43-60. Springer.</Citation></Reference><Reference><Citation>de la Fuente, S. et&#xa0;al. 2013. Ca2+ homeostasis in the endoplasmic reticulum measured with a new low-Ca2+-affinity targeted aequorin. Cell Calcium 54: 37-45.</Citation></Reference><Reference><Citation>DeLuca, H.F. &amp; G. Engstrom. 1961. Calcium uptake by rat kidney mitochondria. Proc. Natl. Acad. Sci. USA 47: 1744-1750.</Citation></Reference><Reference><Citation>Pinton, P. et&#xa0;al. 2001. The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J. 20: 2690-2701.</Citation></Reference><Reference><Citation>Patterson, R.L., D. Boehning &amp; S.H. Snyder. 2004. Inositol 1, 4, 5-trisphosphate receptors as signal integrators. Annu. Rev. Biochem. 73: 437-465.</Citation></Reference><Reference><Citation>Van Rossum, D.B. et&#xa0;al. 2004. Agonist-induced Ca2+ entry determined by inositol 1, 4, 5-trisphosphate recognition. Proc. Natl. Acad. Sci. USA 101: 2323-2327.</Citation></Reference><Reference><Citation>Csord&#xe1;s, G. et&#xa0;al. 2010. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol. Cell 39: 121-132.</Citation></Reference><Reference><Citation>Shin, D.M. &amp; S. Muallem. 2010. What the mitochondria see. Mol. Cell 39: 6-7.</Citation></Reference><Reference><Citation>Z&#xfc;ndorf, G. &amp; G. Reiser. 2011. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid. Redox Signal. 14: 1275-1288.</Citation></Reference><Reference><Citation>Aufschnaiter, A. et&#xa0;al. 2017. Mitochondrial lipids in neurodegeneration. Cell Tissue Res. 367: 125-140.</Citation></Reference><Reference><Citation>Area-Gomez, E. &amp; E.A. Schon. 2016. Mitochondria-associated ER membranes and Alzheimer disease. Curr. Opin. Genet. Dev. 38: 90-96.</Citation></Reference><Reference><Citation>Rusinol, A.E. et&#xa0;al. 1994. A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J. Biol. Chem. 269: 27494-27502.</Citation></Reference><Reference><Citation>Stone, S.J. et&#xa0;al. 2009. The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria. J. Biol. Chem. 284: 5352-5361.</Citation></Reference><Reference><Citation>Stone, S.J. &amp; J.E. Vance. 2000. Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes. J. Biol. Chem. 44: 34534-34540.</Citation></Reference><Reference><Citation>Cui, Z. et&#xa0;al. 1993. Cloning and expression of a novel phosphatidylethanolamine N-methyltransferase. A specific biochemical and cytological marker for a unique membrane fraction in rat liver. J. Biol. Chem. 268: 16655-16663.</Citation></Reference><Reference><Citation>Lewin, T.M. et&#xa0;al. 2002. Rat liver acyl-CoA synthetase 4 is a peripheral-membrane protein located in two distinct subcellular organelles, peroxisomes, and mitochondrial-associated membrane. Arch. Biochem. Biophys. 404: 263-270.</Citation></Reference><Reference><Citation>Vance, J.E. 2014. MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond. Biochim. Biophys. Acta 1841: 595-609.</Citation></Reference><Reference><Citation>Prasad, M. et&#xa0;al. 2015. Mitochondria-associated endoplasmic reticulum membrane (MAM) regulates steroidogenic activity via steroidogenic acute regulatory protein (StAR)-voltage-dependent anion channel 2 (VDAC2) interaction. J. Biol. Chem. 290: 2604-2616.</Citation></Reference><Reference><Citation>Issop, L. et&#xa0;al. 2015. Mitochondria-associated membrane formation in hormone-stimulated Leydig cell steroidogenesis: role of ATAD3. Endocrinology 156: 334-345.</Citation></Reference><Reference><Citation>Hayashi, T. &amp; M. Fujimoto. 2010. Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction. Mol. Pharmacol. 77: 517-528.</Citation></Reference><Reference><Citation>Elbaz-Alon, Y. et&#xa0;al. 2015. Lam6 regulates the extent of contacts between organelles. Cell Rep. 12: 7-14.</Citation></Reference><Reference><Citation>Gatta, A.T. et&#xa0;al. 2015. A new family of StART domain proteins at membrane contact sites has a role in ER-PM sterol transport. elife 4: e07253.</Citation></Reference><Reference><Citation>Friedman, J.R. et&#xa0;al. 2011. ER tubules mark sites of mitochondrial division. Science 334: 358-362.</Citation></Reference><Reference><Citation>Youle, R.J. &amp; A.M. Van Der Bliek. 2012. Mitochondrial fission, fusion, and stress. Science 337: 1062-1065.</Citation></Reference><Reference><Citation>Hoppins, S. &amp; J. Nunnari. 2012. Mitochondrial dynamics and apoptosis-the ER connection. Science 337: 1052-1054.</Citation></Reference><Reference><Citation>Otera, H., N. Ishihara &amp; K. Mihara. 2013. New insights into the function and regulation of mitochondrial fission. Biochim. Biophys. Acta 1833: 1256-1268.</Citation></Reference><Reference><Citation>Smirnova, E. et&#xa0;al. 2001. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. Cell 12: 2245-2256.</Citation></Reference><Reference><Citation>Zhao, J. et&#xa0;al. 2011. Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission. EMBO J. 30: 2762-2778.</Citation></Reference><Reference><Citation>Korobova, F., V. Ramabhadran &amp; H.N. Higgs. 2013. An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2. Science 339: 464-467.</Citation></Reference><Reference><Citation>Koshiba, T. et&#xa0;al. 2004. Structural basis of mitochondrial tethering by mitofusin complexes. Science 305: 858-862.</Citation></Reference><Reference><Citation>Sugiura, A. et&#xa0;al. 2013. MITOL regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2. Mol. Cell 51: 20-34.</Citation></Reference><Reference><Citation>Lin, X. et&#xa0;al. 2013. Interaction domains of p62: a bridge between p62 and selective autophagy. DNA Cell Biol. 32: 220-227.</Citation></Reference><Reference><Citation>Sanjuan, M.A. &amp; D.R. Green. 2008. Eating for good health: linking autophagy and phagocytosis in host defense. Autophagy 4: 607-611.</Citation></Reference><Reference><Citation>Mansilla Pareja, M.E. &amp; M.I. Colombo. 2013. Autophagic clearance of bacterial pathogens: molecular recognition of intracellular microorganisms. Front. Cell. Infect. Microbiol. 3: 54.</Citation></Reference><Reference><Citation>Cebollero, E., F. Reggiori &amp; C. Kraft. 2012. Reticulophagy and ribophagy: regulated degradation of protein production factories. Int. J. Cell Biol. 2012. http://doi.org/10.1155/2012/182834.</Citation></Reference><Reference><Citation>Rimessi, A. et&#xa0;al. 2013. Perturbed mitochondrial Ca2+ signals as causes or consequences of mitophagy induction. Autophagy 9: 1677-1686.</Citation></Reference><Reference><Citation>East, D.A. &amp; M. Campanella. 2013. Ca2+ in quality control: an unresolved riddle critical to autophagy and mitophagy. Autophagy 9: 1710-1719.</Citation></Reference><Reference><Citation>Youle, R.J. &amp; D.P. Narendra. 2011. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 12: 9-14.</Citation></Reference><Reference><Citation>Kesharwani, R. et&#xa0;al. 2019. Interplay between mitophagy and inflammasome in neurological disorders. ACS Chem. Neurosci. 10: 2195-2208.</Citation></Reference><Reference><Citation>Klionsky, D.J. et&#xa0;al. 2003. A unified nomenclature for yeast autophagy-related genes. Dev. Cell 5: 539-545.</Citation></Reference><Reference><Citation>Axe, E.L. et&#xa0;al. 2008. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J. Cell Biol. 182: 685-701.</Citation></Reference><Reference><Citation>Hailey, D.W. et al. 2010. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 141: 656-667.</Citation></Reference><Reference><Citation>Hamasaki, M. et&#xa0;al. 2013. Autophagosomes form at ER-mitochondria contact sites. Nature 495: 389-393.</Citation></Reference><Reference><Citation>Bui, M. et&#xa0;al. 2010. Rab32 modulates apoptosis onset and mitochondria-associated membrane (MAM) properties. J. Biol. Chem. 285: 31590-31602.</Citation></Reference><Reference><Citation>Hirota, Y. &amp; Y. Tanaka. 2009. A small GTPase, human Rab32, is required for the formation of autophagic vacuoles under basal conditions. Cell. Mol. Life Sci. 66: 2913-2932.</Citation></Reference><Reference><Citation>Missiroli, S. et&#xa0;al. 2018. Mitochondria-associated membranes (MAMs) and inflammation. Cell Death Dis. 9: 329.</Citation></Reference><Reference><Citation>Zhou, R. et&#xa0;al. 2011. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225.</Citation></Reference><Reference><Citation>Salaro, E. et&#xa0;al. 2016. Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. Sci. Rep. 6: 26280.</Citation></Reference><Reference><Citation>Jo, E.-K. et&#xa0;al. 2016. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 13: 148-159.</Citation></Reference><Reference><Citation>Di Virgilio, F. et&#xa0;al. 2017. The P2X7 receptor in infection and inflammation. Immunity 47: 15-31.</Citation></Reference><Reference><Citation>Horng, T. 2014. Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome. Trends Immunol. 35: 253-261.</Citation></Reference><Reference><Citation>Lee, G.-S. et&#xa0;al. 2012. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca 2+ and cAMP. Nature 492: 123-127.</Citation></Reference><Reference><Citation>Bonora, M. &amp; P. Pinton. 2014. The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death. Front. Oncol. 4: 302.</Citation></Reference><Reference><Citation>Misawa, T. et&#xa0;al. 2013. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 14: 454-460.</Citation></Reference><Reference><Citation>Manfredi, G. &amp; H. Kawamata. 2016. Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis. Neurobiol. Dis. 90: 35-42.</Citation></Reference><Reference><Citation>Zhu, Y. et&#xa0;al. 2015. Neuroprotective agents target molecular mechanisms of disease in ALS. Drug Discov. Today 20: 65-75.</Citation></Reference><Reference><Citation>Pandya, R.S. et&#xa0;al. 2012. Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy. Cent. Nerv. Syst. Agents Med. Chem. 12: 15-27.</Citation></Reference><Reference><Citation>Pandya, R.S. et&#xa0;al. 2013. Therapeutic neuroprotective agents for amyotrophic lateral sclerosis. Cell. Mol. Life Sci. 70: 4729-4745.</Citation></Reference><Reference><Citation>Marangi, G. &amp; B.J. Traynor. 2015. Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res. 1607: 75-93.</Citation></Reference><Reference><Citation>Johnson, J.O. et&#xa0;al. 2014. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17: 664-666.</Citation></Reference><Reference><Citation>Ling, S.-C., M. Polymenidou &amp; D.W. Cleveland. 2013. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79: 416-438.</Citation></Reference><Reference><Citation>Stoica, R. et&#xa0;al. 2016. ALS/FTD-associated FUS activates GSK-3&#x3b2;; to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations. EMBO Rep. 17: 1326-1342.</Citation></Reference><Reference><Citation>Grosskreutz, J., L. Van Den Bosch &amp; B.U. Keller. 2010. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47: 165-174.</Citation></Reference><Reference><Citation>Guardia-Laguarta, C. et&#xa0;al. 2014. &#x3b1;-Synuclein is localized to mitochondria-associated ER membranes. J. Neurosci. 34: 249-259.</Citation></Reference><Reference><Citation>Cal&#xec;, T. et&#xa0;al. 2012. &#x3b1;-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. J. Biol. Chem. 287: 17914-17929.</Citation></Reference><Reference><Citation>Rane, P. et&#xa0;al. 2018. Novel targets for Parkinson's disease: addressing different therapeutic paradigms and conundrums. ACS Chem. Neurosci. 10: 44-57.</Citation></Reference><Reference><Citation>Bouman, L. et&#xa0;al. 2011. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ. 18: 769-782.</Citation></Reference><Reference><Citation>Cal&#xec;, T. et&#xa0;al. 2013. Enhanced Parkin levels favor ER-mitochondria crosstalk and guarantee Ca2+ transfer to sustain cell bioenergetics. Biochim. Biophys. Acta 1832: 495-508.</Citation></Reference><Reference><Citation>Zheng, L. et&#xa0;al. 2017. Parkin functionally interacts with PGC-1&#x3b1; to preserve mitochondria and protect dopaminergic neurons. Hum. Mol. Genet. 26: 582-598.</Citation></Reference><Reference><Citation>Gautier, C.A. et&#xa0;al. 2016. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations. Hum. Mol. Genet. 25: 2972-2984.</Citation></Reference><Reference><Citation>Gelmetti, V. et&#xa0;al. 2017. PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation. Autophagy 13: 654-669.</Citation></Reference><Reference><Citation>Lin, M.K. &amp; M.J. Farrer. 2014. Genetics and genomics of Parkinson's disease. Genome Med. 6: 48.</Citation></Reference><Reference><Citation>Ottolini, D. et&#xa0;al. 2013. The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering. Hum. Mol. Genet. 22: 2152-2168.</Citation></Reference><Reference><Citation>Liu, Y. &amp; X. Zhu. 2017. Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases. Transl. Neurodegen. 6: 21.</Citation></Reference><Reference><Citation>Paillusson, S. et&#xa0;al. 2016. There's something wrong with my MAM; the ER-mitochondria axis and neurodegenerative diseases. Trends Neurosci. 39: 146-157.</Citation></Reference><Reference><Citation>Rodriguez-Arribas, M. et&#xa0;al. 2017. Mitochondria-associated membranes (MAMs): overview and its role in Parkinson's disease. Mol. Neurobiol. 54: 6287-6303.</Citation></Reference><Reference><Citation>Vila, M., D. Ramonet &amp; C. Perier. 2008. Mitochondrial alterations in Parkinson's disease: new clues. J. Neurochem. 107: 317-328.</Citation></Reference><Reference><Citation>Mercado, G., P. Vald&#xe9;s &amp; C. Hetz. 2013. An ERcentric view of Parkinson's disease. Trends Mol. Med. 19: 165-175.</Citation></Reference><Reference><Citation>Nixon, R.A. 2013. The role of autophagy in neurodegenerative disease. Nat. Med. 19: 983-997.</Citation></Reference><Reference><Citation>Pravalika, K. et&#xa0;al. 2018. Myeloperoxidase and neurological disorder: a crosstalk. ACS Chem. Neurosci. 9: 421-430.</Citation></Reference><Reference><Citation>Filadi, R., P. Theurey &amp; P. Pizzo. 2017. The endoplasmic reticulum-mitochondria coupling in health and disease: molecules, functions and significance. Cell Calcium 62: 1-15.</Citation></Reference><Reference><Citation>Saraf, J. et&#xa0;al. 2018. A friend or foe: calcineurin across the gamut of neurological disorders. ACS Cent. Sci. 4: 805-819.</Citation></Reference><Reference><Citation>Area-Gomez, E. et&#xa0;al. 2009. Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am. J. Pathol. 175: 1810-1816.</Citation></Reference><Reference><Citation>Kopec, K.O., V. Alva &amp; A.N. Lupas. 2010. Homology of SMP domains to the TULIP superfamily of lipid-binding proteins provides a structural basis for lipid exchange between ER and mitochondria. Bioinformatics 26: 1927-1931.</Citation></Reference><Reference><Citation>Sepulveda-Falla, D. et&#xa0;al. 2014. Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis. J. Clin. Invest. 124: 1552-1567.</Citation></Reference><Reference><Citation>Kipanyula, M.J. et&#xa0;al. 2012. Ca2+ dysregulation in neurons from transgenic mice expressing mutant presenilin 2. Aging Cell 11: 885-893.</Citation></Reference><Reference><Citation>Hedskog, L. et&#xa0;al. 2013. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc. Natl. Acad. Sci. USA 110: 7916-7921.</Citation></Reference><Reference><Citation>Leal, N.S. et&#xa0;al. 2016. Mitofusin-2 knockdown increases ER-mitochondria contact and decreases amyloid &#x3b2;-peptide production. J. Cell. Mol. Med. 20: 1686-1695.</Citation></Reference><Reference><Citation>Sarmah, D. et&#xa0;al. 2018. Mitochondrial dysfunction in stroke: implications of stem cell therapy. Transl. Stroke Res. http://doi.org/10.1007/s12975-018-0642-y.</Citation></Reference><Reference><Citation>Rizzuto, R. et&#xa0;al. 2009. Ca2+ transfer from the ER to mitochondria: when, how and why. Biochim. Biophys. Acta 1787: 1342-1351.</Citation></Reference><Reference><Citation>Scorrano, L. et&#xa0;al. 2003. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300: 135-139.</Citation></Reference><Reference><Citation>Wanve, M. et&#xa0;al. 2019. Therapeutic spectrum of interferon-&#x3b2; in ischemic stroke. J. Neurosci. Res. 97: 116-127.</Citation></Reference><Reference><Citation>Ruiz, A., C. Matute &amp; E. Alberdi. 2009. Endoplasmic reticulum Ca2+ release through ryanodine and IP3 receptors contributes to neuronal excitotoxicity. Cell Calcium 46: 273-281.</Citation></Reference><Reference><Citation>Ouyang, Y.B. et&#xa0;al. 1997. Release of mitochondrial aspartate aminotransferase (mAST) following transient focal cerebral ischemia suggests the opening of a mitochondrial permeability transition pore. Neurosci. Res. Commun. 20: 167-173.</Citation></Reference><Reference><Citation>Kirichok, Y., G. Krapivinsky &amp; D.E. Clapham. 2004. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 427: 360-364.</Citation></Reference><Reference><Citation>Bernardi, P. 1999. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 79: 1127-1155.</Citation></Reference><Reference><Citation>Hayashi, T. et&#xa0;al. 2009. MAM: more than just a housekeeper. Trends Cell Biol. 19: 81-88.</Citation></Reference><Reference><Citation>Naia, L. et&#xa0;al. 2017. Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases-role of ER-mitochondria crosstalk. Biochem. Biophys. Res. Commun. 483: 1069-1077.</Citation></Reference><Reference><Citation>Sun, Y. et&#xa0;al. 2001. Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95. J. Biol. Chem. 276: 24713-24718.</Citation></Reference><Reference><Citation>Yano, H. et&#xa0;al. 2014. Inhibition of mitochondrial protein import by mutant huntingtin. Nat. Neurosci. 17: 822-831.</Citation></Reference><Reference><Citation>De Mario, A. et&#xa0;al. 2016. Calcium handling by endoplasmic reticulum and mitochondria in a cell model of Huntington's disease. PLoS Curr. 8. http://doi.org/10.1371/currents.hd.37fcb1c9a27503dc845594ee4a7316c3.</Citation></Reference><Reference><Citation>Al-Saif, A., F. Al-Mohanna &amp; S. Bohlega. 2011. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 70: 913-919.</Citation></Reference><Reference><Citation>Israelson, A. et&#xa0;al. 2010. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 67: 575-587.</Citation></Reference><Reference><Citation>Pham, A.H. et&#xa0;al. 2012. Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit. Hum. Mol. Genet. 21: 4817-4826.</Citation></Reference><Reference><Citation>Bernard-Marissal, N., R. Chrast &amp; B.L. Schneider. 2018. Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship? Cell Death Dis. 9: 333.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>